At Veeva Commercial Summit late 2024, web editor Nicole Raleigh spoke with Veeva Systems’ president of Europe, Chris Moore, for a discursive dive into the life sciences during the year.
Just hours after the confirmation of Robert F Kennedy Jr as Health and Human Services Secretary, President Trump issued an ...
Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...
Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab ...
The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...
Apple has teamed up with Brigham and Women's Hospital on a major new study looking at how devices like the iPhone, Apple ...
CSL has been given approval by the European Commission for Andembry, the first once-monthly preventive therapy for the ...
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D ...
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
The Swiss biopharma company said the deal with the German National Association of Statutory Health Insurance Funds (GKV-SV) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback